DISCLAIMER: This translation may be used for reference purposes only. This English version is not an official translation of
the original Japanese document. In cases where any differences occur between the English version and the original Japaneseversion, the Japanese version shall prevail. This translation is subject to change without notice.

Consolidated Financial Results for the First Six Months of
the Fiscal Year Ending March 31, 2023
<under Japanese GAAP>
October 31, 2022
ORGANO CORPORATIONTokyo Stock Exchange
6368
https://www.organo.co.jp/english/
Masayuki Yamada, Representative Director and President
Shigeru Sonobe, General Manager of Accounting Dept., Corporate Management andPlanning
TEL:+81-3-5635-5111
Scheduled date to file quarterly securities report:
November 9, 2022
Scheduled date to commence dividend payments:
December 5, 2022
Preparation of supplementary material on quarterly financial results: Yes
Holding of quarterly financial results presentation meeting:Yes (for institutional investors andanalysts)
Company name:
Listing:
Securities code:
URL:
Representative:
Inquiries:(Millions of yen with fractional amounts discarded, unless otherwise noted)

1. Consolidated financial results for the first six months of the fiscal year ending March 31, 2023
(from April 1, 2022 to September 30, 2022)(1) Consolidated operating results (cumulative)
Net sales(Percentages indicate year-on-year changes.)

Operating profit

Millions of yen% Millions of yen%
Six months ended
September 30, 2022
62,117
24.2
6,510
72.6
September 30, 2021
50,001
10.3
3,771
18.5
Note:
Comprehensive income: Six months ended September 30, 2022
Six months ended September 30, 2021

Basic earnings
per share

Profit attributable toowners of parent

Ordinary profit
Millions of yen%

Millions of yen

%

7,451
77.7
4,193
28.0
¥6,231 million [93.5%]¥3,220 million [55.4%]

5,027
2,696

86.4
29.6

Diluted earnings
per share

Yen
Yen
Six months ended
September 30, 2022
109.67–
September 30, 2021
58.70–
The Company conducted a 4-for-1 common share split effective as of October 1, 2022. Basic earnings per share are calculatedon the assumption that said share split was conducted at the beginning of the previous fiscal year.

(2) Consolidated financial position
Total assets
Millions of yen
As ofSeptember 30, 2022
143,400
March 31, 2022
130,506(Reference) Equity: As of September 30, 2022 ¥81,145 million

Net assets

Equity-to-asset ratio

Millions of yen

81,34676,004As of March 31, 2022

%

56.6
58.1
¥75,836 million

2. Cash dividends
Annual dividends per shareFirst quarter-end Second quarter-end Third quarter-end
Yen

Fiscal year ended
March 31, 2022
Fiscal year ending
March 31, 2023

Yen

–

72.00

–

116.00Fiscal year-end

Yen

Total

Yen

–

Yen

88.00

160.00Fiscal year ending
–
29.00
–
March 31, 2023
(Forecast)
Note:
Revisions to the forecast of cash dividends most recently announced: None
The Company conducted a 4-for-1 common share split effective as of October 1, 2022. The year-end dividend per share forthe fiscal year ending March 31, 2023 (forecast) stated taking into account the effect of such share split, and the total annual
dividend is stated as “–.” The year-end dividend per share for the fiscal year ending March 31, 2023 (forecast) that does nottake the share split into account is ¥116, and the annual total of dividends per share is ¥232.

3. Consolidated earnings forecasts for the fiscal year ending March 31, 2023
(from April 1, 2022 to March 31, 2023)(Percentages indicate year-on-year changes.)
Net sales
Millionsof yenOperating profit%

Millionsof yenProfit attributable toowners of parent

Ordinary profit%

Millionsof yen%Millionsof yen%Basicearnings
per share
Yen

Fiscal year ending
140,000
24.9
14,50033.6
15,20031.6
11,50024.9
250.86
March 31, 2023
Note:
Revisions to the earnings forecasts most recently announced: None
Basic earnings per share in the consolidated earnings forecasts for the fiscal year ending March 31, 2023 take into accountthe effect of the share split. The forecast for basic earnings per share that does not take the share split into account is¥1,003.44.

* Notes(1) Changes in significant subsidiaries during the period (changes in specified subsidiaries resulting in thechange in scope of consolidation): None
(2) Application of specific accounting for preparing the quarterly consolidated financial statements: Yes
Note:

For more details, please refer to “Application of special accounting for preparing the quarterly consolidated
financial statements” on page 11 of the attached material.

(3) Changes in accounting policies, changes in accounting estimates, and restatementa. Changes in accounting policies due to revisions to accounting standards and other regulations: Noneb. Changes in accounting policies due to other reasons: Nonec. Changes in accounting estimates: None
d. Restatement: None
(4) Number of issued shares (common shares)
a. Total number of issued shares at the end of the period (including treasury shares)
As of September 30, 2022

46,359,700 shares

As of March 31, 2022

46,359,700 sharesb. Number of treasury shares at the end of the period
As of September 30, 2022

470,720 shares

As of March 31, 2022

541,020 sharesc. Average number of shares outstanding during the period (cumulative from the beginning of the fiscal
year)
For the six months ended September 30, 2022

45,842,128 shares

For the six months ended September 30, 2021

45,938,568 shares

Notes:
1. The Company conducted a 4-for-1 common share split effective as of October 1, 2022. Total number of issued
shares at the end of the period, number of treasury shares at the end of the period, and average number of shares
outstanding during the period are calculated on the assumption that said share split was conducted at the
beginning of the previous fiscal year.
2. The Company has introduced an Officer Share Delivery Trust, and shares of the Company held by the Trust
have been included in treasury shares excluded from the calculation of the number of treasury shares at the endof the period and the average number of shares outstanding during the period (cumulative from the beginning of
the fiscal year).

* Quarterly financial results reports are exempt from quarterly review conducted by certified public
accountants or an audit corporation.
* Proper use of earnings forecasts, and other special matters(Caution regarding forward-looking statements and others)
The forward-looking statements, including earnings forecasts, contained in these materials are based on
information currently available to the Company and on certain assumptions deemed to be reasonable.
Consequently, any statements herein do not constitute assurances regarding actual results by theCompany. Actual business and other results may differ substantially due to various factors. Please referto “(3) Explanation regarding consolidated earnings forecasts and other forward-looking statements” in“1. Qualitative information regarding financial results for the first six months” on page 4 of the attachedmaterial for the suppositions that form the assumptions for earnings forecasts and cautions concerning
the use thereof.

Attached Material

Index
1. Qualitative information regarding financial results for the first six months ...................................... 2(1) Explanation regarding operating results .......................................................................................... 2(2) Explanation regarding financial position ......................................................................................... 3(3) Explanation regarding consolidated earnings forecasts and other forward-looking statements 4
2. Quarterly consolidated financial statements and significant notes thereto ........................................ 5(1) Consolidated balance sheet ................................................................................................................ 5(2) Consolidated statement of income and consolidated statement of comprehensive income.......... 7
Consolidated statement of income (cumulative) .............................................................................. 7
Consolidated statement of comprehensive income (cumulative) .................................................... 8(3) Consolidated statement of cash flows ............................................................................................... 9(4) Notes to quarterly consolidated financial statements .................................................................... 11
Notes on premise of going concern .................................................................................................. 11
Notes on substantial changes in the amount of shareholders’ equity ........................................... 11
Application of special accounting for preparing the quarterly consolidated financial statements............................................................................................................................................................ 11
Additional information .................................................................................................................... 11
Segment information, etc. ................................................................................................................ 12
Significant subsequent events .......................................................................................................... 13- 1 -1. Qualitative information regarding financial results for the first six months(1) Explanation regarding operating results
During the six months ended September 30, 2022 (from April 1, 2022 to September 30, 2022), although
the trend in the global economy was one of moderate recovery, the surge in worldwide inflation
originating in energy and food prices, and concerns about slowing business conditions in the US, Europe,and China, due to the impact of monetary tightening among other factors, led to an intensifying sense of
uncertainty regarding the outlook.
With regard to the environment in which the Organo Group operates, our main market of electronics saw
a deterioration in conditions for semiconductor memory against a backdrop of slowing demand forsmartphones, PCs and others, and there are signs that some customers are reducing production andinvestment. However, investment in cutting-edge fields where semiconductor miniaturization is being
driven by competition, and in wafers and legacy semiconductors, remained at high levels. The generalindustry field trended toward recovery, as seen in the execution of capital investment plans that had been
postponed due to the COVID-19 pandemic, and the social infrastructure field, such as electric
power/water supply and sewage, remained strong.
Under these conditions, the Organo Group proceeded to draw in orders and make deliveries for largescale projects in Japan and overseas, while establishing supply chains and delivery frameworks in eachcountry, and promoting a shift to digitalization such as of engineering operations and service solutions.
We also engaged in initiatives to enhance R&D systems in such areas as next-generation ultrapure water
systems and new separation and purification technologies, and to strengthen governance such as bydeveloping risk management systems.
As a result, in the Group’s financial results for the six months ended September 30, 2022, orders received
increased by 32.8% year on year to ¥78,230 million, net sales increased by 24.2% to ¥62,117 million,
operating profit increased by 72.6% to ¥6,510 million, ordinary profit increased by 77.7% to ¥7,451
million, profit attributable to owners of parent increased by 86.4% to ¥5,027 million, and our carry-overbalance for order backlog as of September 30, 2022 was up 52.3% to ¥107,461 million, which were allrecord highs for the first six months.
Results by segment are as follows.
[Water Treatment Engineering Business Unit]■Orders received
Orders received increased 38.7% year on year to ¥67,964 million. In the mainstay electronics field, theOrgano Group succeeded in capturing orders for large-scale projects in Japan, such as semiconductors
and wafers, while investment in cutting-edge semiconductors and other areas in Taiwan also remained athigh levels. There were also investments in major semiconductor projects in China and in successive
major projects in Malaysia, including legacy semiconductors. As a result, orders received expanded
significantly year on year. In the general industry field, there was a recovery in capital investment inareas related to the pharmaceutical and electronics industries. The field of social infrastructure, which
includes electric power/water supply and sewage, recorded a year-on-year decline to the presence in theprevious fiscal year of a major order for a water supply/sewage project, but firm levels of orders wereseen mainly in the Service Solutions Division in Japan.
■Net sales
Net sales increased 29.0% year on year to ¥52,083 million. In the mainstay electronics field, process
delays occurred for some projects as a result of supply shortage of raw materials and other problems,
primarily in the Plant Division. Nevertheless, sales grew due not only to the order backlog carried overfrom the previous year but also due to a large number of construction projects undertaken as a result ofstrong orders continuing in the period under review, the occurrence of translation differences in relation
to overseas net sales as a result of the depreciation of the yen, and strength in maintenance,
renovation/reconditioning, contracted processing services, etc. of the Service Solutions Division. On theother hand, the aforementioned process delays resulted in delays in the recognition of revenue for certain
projects in the general industry field, which caused a slight year-on-year decline in net sales. However,- 2 -in the social infrastructure field, such as electric power/water supply and sewage, progress in construction
for major electric power projects led to a year-on-year increase in sales.
■Operating profit
Operating profit increased 78.6% year on year to ¥5,430 million. Mainly due to the effect of sales
expansion centered on the electronics industry field, the growth in gross profit exceeded that of expenses,
the bulk of which were related to personnel and other items, and resulted in a year-on-year increase inoperating profit.
[Performance Products Business Unit]■Orders received/Net sales
Orders received increased 3.6% year on year to ¥10,266 million and net sales increased 4.3% year on
year to ¥10,034 million. In the water treatment chemicals field, sales of wastewater treatment chemicals,
chemicals for RO membrane treatment, and other chemicals for the electronics industry were steady. In
the standard equipment and filters field, sales of small-scale pure water production equipment grew for
medical institutions and research institutions. This included robust sales of Puric μ (mu), which waslaunched in the previous fiscal year. In the food products field, orders and sales increased primarily forvarious food additives.
■Operating profit
Operating profit increased 47.8% year on year to ¥1,080 million. Due to sales expansion in each of thewater treatment chemical, standard equipment and filters, and food products fields, as well as progress
made in passing on costs in the form of price increases, etc., the Organo Group was able to offset theincrease in raw material prices and costs such as personnel expenses, and record year-on-year growth inprofit.
(2) Explanation regarding financial position
Assets, liabilities and net assets
AssetsAssets as of September 30, 2022 amounted to ¥143,400 million, an increase of ¥12,894 million from theprevious fiscal year end. This was mainly due to increases of ¥9,718 million in notes and accounts
receivable - trade, and contract assets and ¥9,620 million in work in process, despite a decline of ¥7,652
million in cash and deposits.
Liabilities
Liabilities as of September 30, 2022 amounted to ¥62,054 million, an increase of ¥7,552 million fromthe previous fiscal year end. This was mainly due to an increase of ¥5,462 million in short-termborrowings.
Net Assets
Net assets as of September 30, 2022 amounted to ¥81,346 million, an increase of ¥5,341 million fromthe previous fiscal year end. This was mainly due to an increase of ¥4,014 million in retained earnings
resulting from the recording of profit attributable to owners of parent.
Cash flows
Cash and cash equivalents (hereinafter, “cash”) as of September 30, 2022 decreased by ¥7,652 million
from the previous fiscal year end to ¥12,545 million.
Cash flows from operating activities
Net cash used in operating activities for the six months ended September 30, 2022 was ¥10,848 million.
This was mainly because there was an increase in cash due to profit before income taxes of ¥7,446 million
while there was a decrease in cash due to an increase in inventories of ¥10,412 million and an increasein trade receivables and contract assets of ¥7,328 million. (Net cash of ¥3,435 million was used in thesix months ended September 30, 2021.)- 3 -Cash flows from investing activities
Net cash used in investing activities for the six months ended September 30, 2022 was ¥779 million. Thiswas mainly due to purchase of property, plant and equipment of ¥687 million. (Net cash of ¥1,056 million
was used in the six months ended September 30, 2021.)
Cash flows from financing activities
Net cash provided by financing activities for the six months ended September 30, 2022 was ¥3,162
million. This was mainly because there was a decrease in cash due to dividends paid of ¥1,012 million
and repayments of long-term borrowings of ¥1,000 million while there was an increase in cash due to a
net increase in short-term borrowings of ¥5,256 million. (Net cash of ¥2,658 million was used in the six
months ended September 30, 2021.)(3) Explanation regarding consolidated earnings forecasts and other forward-looking statements
Turning to full-year earnings forecast, orders received, net sales, and profits have all exceeded initialplans, and are expected to achieve new record highs for the second consecutive year. With regard toorders received, in our main market of electronics, investment in cutting-edge semiconductors and otherareas in Taiwan is expected to remain at high levels, in addition to which semiconductor investment in
China remains brisk, and orders in Malaysia for legacy semiconductors, among others, are expected to
exceed initial expectations. Accordingly, we anticipate orders received of ¥170,000 million, an increaseof 25.3% year on year. Due to strong orders centered on the electronics industry, we expect overseas sales
in areas such as Taiwan, China, and Malaysia to expand, and thus expect net sales of ¥140,000 million,
an increase of 24.9% year on year. On the profit side, reflecting the impact of expanded sales, we expect
operating profit of ¥14,500 million, up 33.6% year on year, ordinary profit of ¥15,200 million, up 31.6%,
and profit attributable to owners of parent of ¥11,500 million, up 24.9%.

- 4 -2. Quarterly consolidated financial statements and significant notes thereto(1) Consolidated balance sheet(Millions of yen)
As of March 31, 2022

As of September 30, 2022

20,19812,54552,926

62,644

1,862

1,732

11,293
5,264
6,735
1,456
3,133
(6)
102,862

10,086
5,781
16,355
1,825
4,777
(6)
115,743

18,873(12,707)
6,166
5,826
(5,117)709
12,257
1,115
5,346(4,601)
745
20,995
1,082

19,194(12,991)
6,203
6,610
(5,251)
1,358
12,27040
5,753(4,674)
1,079
20,952
995

2,058
624
2,369
979
(464)
5,566
27,644
130,506

2,151
732
2,369
593
(138)
5,707
27,656
143,400

AssetsCurrent assets
Cash and deposits
Notes and accounts receivable - trade, andcontract assets
Electronically recorded monetary claims operating
Investments in leases
Merchandise and finished goods
Work in process
Raw materials and supplies
Other
Allowance for doubtful accounts
Total current assets
Non-current assets
Property, plant and equipment
Buildings and structures
Accumulated depreciation
Buildings and structures, net
Machinery, equipment and vehicles
Accumulated depreciation
Machinery, equipment and vehicles, net
LandConstruction in progress
Other
Accumulated depreciation
Other, net
Total property, plant and equipment
Intangible assets
Investments and other assets
Investment securities
Retirement benefit asset
Deferred tax assets
Other
Allowance for doubtful accounts
Total investments and other assets
Total non-current assets
Total assets- 5 -(Millions of yen)
As of March 31, 2022

As of September 30, 2022

18,795
5,575
9,933
1,444
1,820
1,477
296
46

18,1407,270
15,395
2,113
3,701
1,762
354
35

123

50

3,559
43,072

2,554
51,378

5,695
53
5,512
168
11,42954,501

4,695
185
5,633
161
10,67562,0548,225
7,508
59,619(734)
74,6178,225
7,508
63,633(612)
78,755

434

401

(0)
575
208
1,218
168
76,004
130,506

–
1,767
221
2,390
200
81,346
143,400

Liabilities
Current liabilities
Notes and accounts payable - trade
Electronically recorded obligations - operating
Short-term borrowings
Income taxes payable
Contract liabilities
Provision for bonuses
Provision for product warranties
Provision for loss on construction contracts
Provision for share awards for directors (andother officers)
Other
Total current liabilities
Non-current liabilities
Long-term borrowings
Deferred tax liabilities
Retirement benefit liability
Other
Total non-current liabilities
Total liabilities
Net assets
Shareholders’ equity
Share capital
Capital surplus
Retained earnings
Treasury shares
Total shareholders’ equity
Accumulated other comprehensive income
Valuation difference on available-for-salesecurities
Deferred gains or losses on hedges
Foreign currency translation adjustment
Remeasurements of defined benefit plans
Total accumulated other comprehensive income
Non-controlling interests
Total net assets
Total liabilities and net assets- 6 -(2) Consolidated statement of income and consolidated statement of comprehensive income
Consolidated statement of income (cumulative)

Net sales
Cost of sales
Gross profit
Selling, general and administrative expenses
Operating profit
Non-operating income
Interest income
Dividend income
Foreign exchange gains
Share of profit of entities accounted for using
equity method
Other
Total non-operating income
Non-operating expenses
Interest expenses
Loss on valuation of derivatives
Other
Total non-operating expenses
Ordinary profit
Extraordinary income
Gain on sale of non-current assets
Gain on sale of investment securities
Gain on sale of right to use facilities
Total extraordinary income
Extraordinary losses
Loss on abandonment of non-current assets
Loss on sale of right to use facilities
Total extraordinary losses
Profit before income taxes
Income taxes
ProfitProfit attributable to non-controlling interests
Profit attributable to owners of parent

Six months ended
September 30, 2021
(From April 1, 2021 toSeptember 30, 2021)
50,001
37,597
12,404
8,632
3,771

- 7 -

(Millions of yen)Six months ended
September 30, 2022
(From April 1, 2022 toSeptember 30, 2022)
62,11746,00916,108
9,597
6,510

11
16
381

14
21
909

60

100

48
520

95
1,140

53
38
5
97
4,193

72
123
4
200
7,451

–
22
11
34

4
2
–
6

12
13
25
4,202
1,501
2,700
3
2,696

11
–
11
7,446
2,410
5,035
7
5,027

Consolidated statement of comprehensive income (cumulative)

ProfitOther comprehensive income
Valuation difference on available-for-salesecurities
Deferred gains or losses on hedges
Foreign currency translation adjustment
Remeasurements of defined benefit plans, net oftax
Share of other comprehensive income of entities
accounted for using equity method
Total other comprehensive income
Comprehensive income
Comprehensive income attributable toComprehensive income attributable to owners ofparentComprehensive income attributable to noncontrolling interests

Six months ended
September 30, 2021
(From April 1, 2021 toSeptember 30, 2021)
2,700

- 8 -

(Millions of yen)Six months ended
September 30, 2022
(From April 1, 2022 toSeptember 30, 2022)
5,035

(5)

(33)

–
493

0
1,215

32

13

(1)

(0)

520
3,220

1,195
6,231

3,210

6,199

9

31

(3) Consolidated statement of cash flows
Six months ended
September 30, 2021
(From April 1, 2021 toSeptember 30, 2021)
Cash flows from operating activities
Profit before income taxes
Depreciation
Increase (decrease) in provisions
Increase (decrease) in retirement benefit liability
Decrease (increase) in retirement benefit asset
Interest and dividend income
Interest expenses
Foreign exchange losses (gains)Share of loss (profit) of entities accounted forusing equity method
Loss (gain) on valuation of derivatives
Loss on abandonment of non-current assets
Loss (gain) on sale of property, plant andequipment
Loss (gain) on sale of investment securities
Loss (gain) on sale of right to use facilities
Decrease (increase) in trade receivables andcontract assets
Decrease (increase) in investments in leases
Decrease (increase) in inventories
Increase (decrease) in trade payables
Other, net
SubtotalInterest and dividends received
Interest paid
Income taxes refund (paid)
Other, net
Net cash provided by (used in) operating activities
Cash flows from investing activities
Purchase of property, plant and equipment
Proceeds from sale of property, plant andequipment
Purchase of intangible assets
Purchase of investment securities
Proceeds from sale of investment securities
Proceeds from collection of loans receivable
Proceeds from sale of right to use facilities
Other, net
Net cash provided by (used in) investing activities- 9 -(Millions of yen)Six months ended
September 30, 2022
(From April 1, 2022 toSeptember 30, 2022)

4,202
594
188
101
(128)
(28)
53
(37)

7,446
798
35
140
(121)
(35)
72
(385)

(60)

(100)

38
12

123
11

–

(4)

(22)
1

(2)
–

(2,939)(7,328)(2,772)
1,902(2,679)444(1,127)40(63)(2,286)2(3,435)

1,206(10,412)
(223)
(479)
(9,258)48(77)(1,628)66(10,848)

(974)

(687)

–

5

(166)
(7)
63
–
32
(4)
(1,056)

(96)
(299)
6
300
–
(7)
(779)

Six months ended
September 30, 2021
(From April 1, 2021 toSeptember 30, 2021)
Cash flows from financing activities
Net increase (decrease) in short-term borrowings
Repayments of long-term borrowings
Dividends paid
Other, net
Net cash provided by (used in) financing activities
Effect of exchange rate change on cash and cash
equivalents
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Increase in cash and cash equivalents resulting from
inclusion of subsidiaries in consolidation
Cash and cash equivalents at end of period- 10 -(Millions of yen)Six months ended
September 30, 2022
(From April 1, 2022 toSeptember 30, 2022)(1,628)
(300)
(713)
(16)
(2,658)5,256(1,000)(1,012)
(81)
3,162

199

813

(6,950)12,804(7,652)
20,198

314

–

6,168

12,545

(4) Notes to quarterly consolidated financial statements
Notes on premise of going concern
No items to report
Notes on substantial changes in the amount of shareholders’ equity
No items to report
Application of special accounting for preparing the quarterly consolidated financial statements
Calculation of tax expenses
The Company and some of its consolidated subsidiaries have reasonably estimated the effective tax rate
after the application of tax effect accounting to the profit before income taxes for the fiscal year including
the second quarter ended September 30, 2022, and tax expenses are calculated by multiplying profit
before income taxes by this estimated effective tax rate. However, in cases where the calculation of tax
expenses using such estimated effective tax rate yields a result that is not reasonable to a significant
extent, the amount of significant difference other than temporary differences, etc. is added to or deductedfrom the profit before income taxes, and the result is multiplied by the statutory income tax rate.
Additional information
Impact arising due to the proliferation of COVID-19
There has been no material change in the assumptions regarding the impact of COVID-19 described in
the annual securities report (Additional information) (Impact arising due to the proliferation of COVID19) for the previous fiscal year.

- 11 -

Segment information, etc.
[Segment information]
I Six months ended September 30, 2021 (From April 1, 2021 to September 30, 2021)
1. Information relating to net sales and profit by each reportable segment
Reportable Segment(Millions of yen)Amountrecorded in the
consolidated
statement ofincome(Note)

Water
Treatment
Engineering
Business Unit

Performance
Products
Business Unit

Net sales
Sales to external customers
Intersegment sales or transfers

40,378
0

9,623
166

50,001
166

–
(166)

50,001–

Total

40,378

9,789

50,168(166)

50,001

Total

Adjustment

Segment profit
3,040
730
3,771
–
3,771
Note:
The figures for segment profit are based on operating profit, and there are no discrepancies with the operating profit
shown in the consolidated statement of income.

II Six months ended September 30, 2022 (From April 1, 2022 to September 30, 2022)
1. Information relating to net sales and profit by each reportable segment
Reportable Segment(Millions of yen)Amountrecorded in the
consolidated
statement ofincome(Note)

Water
Treatment
Engineering
Business Unit

Performance
Products
Business Unit

Net sales
Sales to external customers
Intersegment sales or transfers

52,0830

10,034
179

62,117
179

–
(179)

62,117–

Total

52,083

10,21462,297(179)

62,117

Total

Adjustment

Segment profit
5,430
1,080
6,510
–
6,510
Note:
The figures for segment profit are based on operating profit, and there are no discrepancies with the operating profit
shown in the consolidated statement of income.

- 12 -

Significant subsequent events
Share split and partial amendments to the Articles of Incorporation in accordance with the share split
The Company resolved at a meeting of its Board of Directors held on May 12, 2022, to implement a
share split and make partial amendments to the Articles of Incorporation in relation to the share split. The
resolution took effect on October 1, 2022.
(1) Purpose of the share split
The purpose of the share split is to create a more investment-friendly environment and broaden theinvestment base by reducing the price per investment unit of the Company’s shares.
(2) Outline of the share split(i) Method of share split
The Company implemented a 4-for-1 share split of common shares owned by shareholders recordedin the closing register of shareholders with a record date of September 30, 2022.
(ii) Increase in the number of shares due to the share split
Total number of issued shares before the share split
Increase in the number of shares due to the share split
Total number of issued shares after the share split
Total number of shares authorized to be issued after the share split(iii) Schedule of the share split
Public notice of record date:
Record date:
Effective date:

11,589,925 shares
34,769,775 shares
46,359,700 shares
101,568,000 shares

September 14, 2022
September 30, 2022
October 1, 2022(iv) Effect on per share information
The effect on per share information is presented in the relevant location.
(3) Partial amendments to the Articles of Incorporation in relation to the share split(i) Reason for the amendments to the Articles of Incorporation
In conjunction with the share split, pursuant to Article 184, paragraph 2 of the Companies Act, theCompany amended the total number of authorized shares prescribed in Article 6 (Total Number of
Shares Authorized to Be Issued) of the Articles of Incorporation of the Company on October 1, 2022.
(ii) Details of the amendments to the Articles of Incorporation
The details of the amendments are as follows.
(Underlines indicate amended sections)
Before Amendments
Article 6. (Total Number of Shares Authorized to Be
Issued)The total number of shares authorized to be issued by
the Company shall be 25,392,000 shares.

After Amendments
Article 6. (Total Number of Shares Authorized to Be
Issued)The total number of shares authorized to be issued by
the Company shall be 101,568,000 shares.

(iii) Schedule for the amendments to the Articles of Incorporation
Date of Board of Directors resolution:
May 12, 2022
Effective date:
October 1, 2022
(4) Other
The amount of the Company’s share capital did not change as a result of the share split.

- 13 -